BioSpace News Archive

Drug Development

Karolinska Development’s portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin

Karolinska Development’s portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD).

January 8, 2019
·
2 min read
Biotech Bay

Apollomics, Inc. (previously CBT Pharmaceuticals, Inc.) Raises $100 Million in Series B Financing

Financing will accelerate development of the Company’s cancer immunotherapy and targeted therapy programs

January 8, 2019
·
3 min read
Business

AYOXXA signs research agreement in the field of ophthalmology with one of the leading pharmaceutical companies

Agreement targets the development of low volume and high sensitivity multiplex assays for aqueous humor protein profiling for biomarker identification and validation in support of drug discovery in ophthalmology

January 8, 2019
·
4 min read
Business

Amgen Execs Speak on Majority of Repatha Medicare Patients Now Having Low-Cost Access

Amgen continues to move toward completing its promise of shifting patients to a cheaper cost of its blockbuster anti-cholesterol drug Repatha, a PCSK9 (proprotein convertase subtilisin kexin type 9) inhibitor.

January 8, 2019
·
2 min read
·
Alex Keown
Business

Sharon Callahan of TBWA/WorldHealth Named 2019 Woman of the Year by the Healthcare Businesswomen’s Association

Sharon Callahan, Chief Executive Officer of TBWA/WorldHealth and Chief Client Officer at Omnicom Health Group, has been named Woman of the Year by the Healthcare Businesswomen’s Association (HBA).

January 8, 2019
·
4 min read
Business

ICON Issues Financial Guidance for Full Year 2019

Announces intention to repurchase up to 1 million shares during 2019.

January 8, 2019
·
4 min read
Business

AgroSavfe Announces Adrian Percy as New Independent Board Member

AgroSavfe NV announced today that it has appointed Dr Adrian Percy as new Board Member to its Board of Directors.

January 8, 2019
·
2 min read
Business

4D pharma plc: Appointment of Independent Non-Executive Directors

4D pharma plc today announces the appointment of Ed Baracchini, PhD, and Professor Axel Glasmacher, MD, as independent Non-Executive Directors with immediate effect.

January 8, 2019
·
3 min read
FSD Pharma Completes Harvest and Passes Analytical Testing of Second Lot

Company in position for pre-sales license inspection, last step to issuance of a Sales License

January 8, 2019
·
3 min read
Business

CANbridge Pharmaceuticals and WuXi Biologics Expand Rare Disease Therapeutics Partnership

CANbridge Pharmaceuticals Inc. and WuXi Biologics jointly announced an expansion of their rare disease partnership to enable CANbridge to discover, develop and commercialize four additional drug candidates

January 8, 2019
·
4 min read